Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$7.12 USD
+0.14 (2.01%)
Updated May 16, 2024 04:00 PM ET
After-Market: $6.88 -0.24 (-3.37%) 6:32 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.12 USD
+0.14 (2.01%)
Updated May 16, 2024 04:00 PM ET
After-Market: $6.88 -0.24 (-3.37%) 6:32 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Zacks News
New Strong Sell Stocks for April 5th
by Zacks Equity Research
FENC, ALKT, and AMADY have been added to the Zacks Rank #5 (Strong Sell) List on April 5, 2022.
Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down
by Zacks Equity Research
Fennec (FENC) suffers a setback again with a CRL for its new drug application (NDA) for Pedmark. Shares are down in pre-market trading.
Adherex Technologies Inc. (FENC) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Adherex Technologies Inc. (FENC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
4 Breakout Stocks for Impressive Returns
by Nitish Marwah
SB, VTSI, FENC and APYX qualified the screen for breakout stocks for today.
Here's Why "Trend" Investors Would Love Betting on Adherex Technologies Inc. (FENC)
by Zacks Equity Research
Adherex Technologies Inc. (FENC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Here's Why Momentum in Adherex Technologies Inc. (FENC) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Adherex Technologies Inc. (FENC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
New Strong Sell Stocks for December 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for November 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for November 19th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Catalyst Focuses on Firdapse Label Expansion Amid Competition
by Zacks Equity Research
Catalyst (CPRX) focuses on the development of Firdapse for additional indications.
Fennec Pharmaceuticals Inc. (FENC) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Fennec Pharmaceuticals Inc. (FENC).